Oracle Healthcare Acquisition Corp. - Current report filing (8-K)
08 5월 2008 - 8:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event
reported):
May 7, 2008
Oracle Healthcare Acquisition
Corp.
(Exact name of registrant as
specified in its charter)
|
Delaware
|
|
000-51785
|
|
26-0126028
|
|
(State or other jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer Identification
No.)
|
200 Greenwich Ave.,
3rd Floor
Greenwich, Connecticut 06830
(Address of principal executive
offices)
(203) 862-7900
(Registrant’s telephone number,
including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2 below):
|
o
|
|
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
|
|
|
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item
3.01.
|
|
Notice
of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
Transfer of Listing.
|
The information
set forth below under Item 8.01 is incorporated herein by reference.
On May 7,
Oracle Healthcare Acquisition Corp. (the “Company”) issued a press release
announcing that its stockholders voted to approve the dissolution of the
Company and its proposed plan of liquidation, as presented in the Company’s
proxy statement dated April 16, 2008, at the special meeting of
stockholders held on May 7, 2008.
The Company also
announced that it expects to pay the liquidating distribution, if any, from the
trust account in which the proceeds from the Company’s initial public offering
were placed on or around May 12, 2008 to stockholders of record on May 7,
2008. The Company also announced that it
has filed a certificate of dissolution with the Secretary of State of the State
of Delaware for the purpose of effecting its dissolution and has filed a
Certificate of Termination of Registration on Form 15 with the Securities
and Exchange Commission for the purpose of deregistering its securities under
the Securities Exchange Act of 1934, as amended. As a result, the Company will no longer be a
public reporting company and its securities will cease trading on the OTC
Bulletin Board.
A copy of the
press release is attached as Exhibit 99.1 and is incorporated in this Item
8.01 by reference.
|
Item
9.01.
|
|
Financial
Statements and Exhibits
|
(d)
Exhibits
|
Exhibit No.
|
|
Description:
|
|
|
|
|
|
Exhibit 99.1
|
|
Press Release, dated
May 7, 2008, issued by Oracle Healthcare Acquisition Corp.
|
2
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
ORACLE HEALTHCARE ACQUISITION CORP.
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Joel D. Liffmann
|
|
Date: May 7, 2008
|
|
Name:
|
Joel D. Liffmann
|
|
|
|
Title:
|
President and Chief Operating Officer
|
3
INDEX TO
EXHIBITS
|
Exhibit No.
|
|
Description:
|
|
|
|
|
|
Exhibit 99.1
|
|
Press Release, dated
May 7, 2008, issued by Oracle Healthcare Acquisition Corp.
|
4
Oracle Healthcare Acquis... (CE) (USOTC:OHAQ)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
Oracle Healthcare Acquis... (CE) (USOTC:OHAQ)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024
